MedPath
HSA Approval

DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml

SIN05868P

DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml

DBL POTASSIUM ACETATE CONCENTRATED INJECTION 2.45 g/5 ml

May 21, 1991

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA17

potassium acetate

Manufacturer Information

PFIZER PRIVATE LIMITED

Siegfried Hameln GmbH

Active Ingredients

POTASSIUM ACETATE (ANHYDROUS)

2.45 g/5 ml

Potassium acetate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.